New Drugs for the Treatment of Parkinson's Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New Drugs for the Treatment of Parkinson's Disease

Published:2000-01 Issue:1 Part 2 Volume:20 Page:26S-32S
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

LeWitt Peter A.

Publisher

Wiley

Subject

Pharmacology (medical)

Reference45 articles.

1. "Early" initiation of levodopa treatment does not promote the development of motor response fluctuations, dyskinesias, or dementia in Parkinson's disease

2. Preclinical pharmacology of ropinirole (SK&F 101468-A) a novel dopamine D2 agonist

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in nanotechnology and its application for neuro-disease: a review;Applied Nanoscience;2023-09

2. Magnolol Protects Against Oxidative Stress-Mediated Neural Cell Damage by Modulating Mitochondrial Dysfunction and PI3K/Akt Signaling;Journal of Molecular Neuroscience;2013-02-14

3. Polyphenol Composition and Antioxidant Potential ofHibiscus esculentusL. Fruit Cultivated in Nigeria;Journal of Medicinal Food;2009-12

4. Protective effect of quercetin in primary neurons against Aβ(1–42): relevance to Alzheimer's disease;The Journal of Nutritional Biochemistry;2009-04

5. Protective effect of Pycnogenol in human neuroblastoma SH-SY5Y cells following acrolein-induced cytotoxicity;Free Radical Biology and Medicine;2008-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3